DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Aminopterin is an investigational drug.
There have been 106 clinical trials for Aminopterin. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2001.
The most common disease conditions in clinical trials are Leukemia, Leukemia, Lymphoid, and Precursor Cell Lymphoblastic Leukemia-Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Children's Oncology Group, and Fred Hutchinson Cancer Research Center.
Recent Clinical Trials for Aminopterin
|DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia||M.D. Anderson Cancer Center||Phase 1/Phase 2|
|Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer||National Cancer Institute (NCI)||Phase 3|
|A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)||National Cancer Institute (NCI)||Phase 2|